Statin use is associated with a lower risk of recurrence after curative resection in BCLC stage 0-A hepatocellular carcinoma

BACKGROUND: Use of statins is associated with a reduced risk of hepatocellular carcinoma (HCC). However, the effect of statin use on HCC recurrence is unclear. This study aimed to evaluate the effect of statin use on recurrence after curative resection among patients with HCC. METHODS: We retrospect...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:BMC Cancer
Hauptverfasser: Yang, Shih-Yu, Wang, Chih-Chi, Chen, Kuang-Den, Liu, Yueh-Wei, Lin, Chih-Che, Chuang, Ching-Hui, Tsai, Yu-Chieh, Yao, Chih-Chien, Yen, Yi-Hao, Hsiao, Chang-Chun, Hu, Tsung-Hui, Tsai, Ming-Chao
Format: Artigo
Sprache:Inglês
Veröffentlicht: BioMed Central 2021
Schlagworte:
Research Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7808883/
https://ncbi.nlm.nih.gov/pubmed/33446127
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-021-07796-7
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge